Database research in transfusion medicine: The power of large numbers

Transfusion

Volumn 55, Issue 7, 2015, Pages 1591-1595

  Kleinman, Steven ^a   Glynn, Simone A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; DATA BASE; DISEASE REGISTRY; DONOR SELECTION; HOSPITAL CARE; HUMAN; MORBIDITY; MORTALITY; REIMBURSEMENT; REVIEW; TRANSFUSION; TRANSFUSION MEDICINE; BLOOD TRANSFUSION; FACTUAL DATABASE; FEMALE; MALE;

BLOOD DONORS; BLOOD TRANSFUSION; DATABASES, FACTUAL; FEMALE; HUMANS; MALE;

EID: 84937010615     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13139     Document Type: Review

References (27)

1. Edgren G, Rostgaard K, Wikman A, et al., The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility. Transfusion 2015; 55: 000-00.
2. Edgren G, Tran TN, Hjalgrim H, et al., Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion 2007; 47: 2017-24.
3. Edgren G, Reilly M, Hjalgrim H, et al., Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst 2008; 100: 572-9.
4. Edgren G, Hjalgrim H, Reilly M, et al., Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet 2007; 369: 1724-30.
5. Kamper-Jorgensen M, Ahlgren M, Rostgaard K, et al., Survival after blood transfusion. Transfusion 2008; 48: 2577-84.
6. Edgren G, Kamper-Jorgensen M, Eloranta S, et al., Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010; 50: 1185-95.
7. Cook JA, Collins GS,. The rise of big clinical databases. Br J Surg 2015; 102: e93-101.
8. Kleinman S, King MR, Busch MP, et al., The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev 2012; 26: 281-304, 304.e1-2.
9. Dodd RY, Notari EP 4th, Stramer SL,. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-9.
10. Custer B, Bravo M, Bruhn R, et al., Predictors of hemoglobin recovery or deferral in blood donors with an initial successful donation. Transfusion 2014; 54: 2267-75.
11. Germain M, Delage G, Blais C, et al., Iron and cardiac ischemia: a natural, quasi-random experiment comparing eligible with disqualified blood donors. Transfusion 2013; 53: 1271-79.
12. Vahidnia F, Hirschler NV, Agapova M, et al., Cancer incidence and mortality in a cohort of US blood donors: a 20-year study. J Cancer Epidemiol 2013; 2013: 814842.
13. Menis M, Anderson SA, Forshee RA, et al., Transfusion-related acute lung injury and potential risk factors among the inpatient US elderly as recorded in Medicare claims data, during 2007 through 2011. Transfusion 2014; 54: 2182-93.
14. Wu WC, Schifftner TL, Henderson WG, et al., Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-88.
15. Yang X, Alexander KP, Chen AY, et al,. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes results from the CRUSADE national quality improvement initiative. J Am Coll Cardiol 2005; 46: 1490-95.
16. Ferraris VA, Davenport DL, Saha SP, et al., Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49-55.
17. Yazer MH, Triulzi DJ,. Things aren't always as they seem: what the randomized trials of red blood cell transfusion tell us about adverse outcomes. Transfusion 2014; 54: 3243-46.
18. Borkent-Raven BA, Janssen MP, van der Poel CL, et al., The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang 2010; 99: 54-64.
19. Borkent-Raven BA, Janssen MP, van der Poel CL, et al., Survival after transfusion in the Netherlands. Vox Sang 2011; 100: 196-203.
20. Roubinian NH, Escobar GJ, Liu V, et al., Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion 2014; 54: 2678-86.
21. Roubinian N, Murphy EL, Swain BE, et al., Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity. BMC Health Serv Res 2014; 14: 213.
22. Frank SM, Resar LM, Rothschild JA, et al., A novel method of data analysis for utilization of red blood cell transfusion. Transfusion 2013; 53: 3052-59.
23. Kleinman S, Busch MP, Murphy EL, et al., The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion 2014; 54: 942-55.
24. Triulzi D, Gottschall J, Murphy E, et al., A multicenter study of plasma use in the United States. Transfusion 2014 [Epub ahead of print].
25. Cooke CR, Iwashyna TJ,. Using existing data to address important clinical questions in critical care. Crit Care Med 2013; 41: 886-96.
26. van Walraven C, Bennett C, Forster AJ,. Administrative database research infrequently used validated diagnostic or procedural codes. J Clin Epidemiol 2011; 64: 1054-59.
27. Lambert L, Blais C, Hamel D, et al., Evaluation of care and surveillance of cardiovascular disease: can we trust medico-administrative hospital data? Can J Cardiol 2012; 28: 162-68.